RxDoctor Payments DataLook up a doctor →

Ricky Hsu, MD

Internal Medicine · New York, NYNPI 1568491967

Payments from drug & device makers

$1,226,175in general payments, 2019–2025

Across 1,608 payments — averaging $762.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$763K
  • Gilead$130K
  • Janssen Products, LP$105K
  • Merck$84K
  • EMD Serono, Inc.$72K
  • Janssen Research & Development, LLC$36K
  • plus $36K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company749$762,767
Gilead232$130,149
Janssen Products, LP108$104,816
Merck138$83,736
EMD Serono, Inc.100$72,088
Janssen Research & Development, LLC13$36,285
GSK14$10,698
Janssen Scientific Affairs, LLC20$8,409
Theratechnologies Inc.24$8,277
Roche Diagnostics International Ltd1$4,144
Johnson & Johnson(2 entities)58$1,531
AbbVie(2 entities)42$819
Bausch Health US, LLC16$317
AstraZeneca11$217
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$168
Antares Pharma, Inc.6$153
Mylan Pharmaceuticals Inc.7$149
Lilly USA, LLC6$130
Takeda Pharmaceuticals U.S.A., Inc.4$127
Otsuka America Pharmaceutical, Inc.5$123
Roche Molecular Systems, Inc.2$108
CSL Behring4$93
Grifols USA, LLC3$81
Napo Pharmaceuticals Inc3$80
Mylan Institutional Inc.4$77
Hologic Sales And Service, LLC3$76
Amarin Pharma, Inc.3$63
Nestle Healthcare Nutrition Inc.3$62
Shire North American Group Inc1$58
Kowa Pharmaceuticals America, Inc.3$53
Paratek Pharmaceuticals, Inc.2$48
Octapharma USA, Inc.2$47
Endo Pharmaceuticals Inc.2$45
Halozyme Inc2$41
Aytu Biopharma, Inc.2$35
Exact Sciences1$25
Neurocrine Biosciences, Inc.1$24
Novo Nordisk1$20
Phadia US Inc.1$20
Oxford Immunotec USA Inc1$16

How this compares

$1,226,175 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024
$158,857
Medicare patients
115
Services billed
2,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →